Company
Headquarters: Solna, Sweden
Employees: 361
kr8.11 Billion
SEK as of July 1, 2024
US$764.5 Million
| Company | Market Cap (USD) |
|---|---|
| Blackstone | $194.86 B |
| BlackRock | $168.35 B |
| KKR & Co. Inc. | $119.35 B |
| Brookfield Corporation | $105.02 B |
| Brookfield Asset Management Ltd. | $86.42 B |
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $1.072 T |
| JPMorgan | $894.99 B |
| Visa | $668.67 B |
| Mastercard | $509.08 B |
| Bank of America | $414.42 B |
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK200 million ($23.06 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.